Development of a COVID-19 Vaccine Hesitancy Single Session Group Intervention for US Veterans

Main Article Content

Emily L Mitchell Sarah R. Sullivan Kyra K Hamerling-Potts Matthew F Dobbs Joseph C Geraci Marianne Goodman


Background: COVID-19 vaccine hesitancy remains problematic and is particularly prevalent in minority and underserved communities.

Aim and Scope: The development and initial efficacy of a single-session Vaccine Hesitancy-focused Telehealth Group at a Veterans hospital in the Bronx, NY are described. This single-session telehealth group integrated motivational interviewing, psychoeducation, and a “vaccine positive” peer with the goal of addressing COVID-19 vaccine hesitancy and improving vaccination rates.

Methods: This project was approved by the quality assurance and improvement team at the James J. Peters VA Medical Center in the Bronx, NY. From the vaccine-hesitant Veteran referrals received from providers, eight vaccine hesitancy groups, averaging 3.5 participants  per session, were conducted. Thirty Veterans total participated in the telehealth group.

Results: Two-thirds of the participants have received the COVID-19 vaccine, with the vast majority of participants receiving the vaccine after the group. About half of the participants (n=14) were more willing to get the vaccine following the intervention and none experienced an increase in hesitancy.

Conclusions: Preliminary results suggest this may be one intervention to increase vaccine acceptability and COVID-19 vaccination rates. Program strengths, limitations, and suggestions are discussed.

Keywords: vaccine hesitancy, COVID-19, SARS-CoV-2, health behaviors, intervention

Article Details

How to Cite
MITCHELL, Emily L et al. Development of a COVID-19 Vaccine Hesitancy Single Session Group Intervention for US Veterans. Medical Research Archives, [S.l.], v. 10, n. 12, dec. 2022. ISSN 2375-1924. Available at: <>. Date accessed: 16 july 2024. doi:
Research Articles


1. HHS Fact Sheet: Explaining Operation Warp Speed. Available at: Accessed on May 13 2021.
2. Khubchandani, J., Sharma, S., Price, J. H., Wiblishauser, M. J., Sharma, M., & Webb, F. J. (2021). COVID-19 vaccination hesitancy in the United States: a rapid national assessment. Journal of Community Health, 46(2), 270-277.
3. Kricorian, K., Civen, R., & Equils, O. (2022). COVID-19 vaccine hesitancy: Misinformation and perceptions of vaccine safety. Human Vaccines & Immunotherapeutics, 18(1), 1950504.
4. Coustasse, A., Kimble, C., & Maxik, K. (2021). COVID-19 and vaccine hesitancy: A challenge the United States must overcome. The Journal of Ambulatory Care Management, 44(1), 71-75.
5. Machingaidze, S. & Wiysonge, C. S. (2021). Understanding COVID-19 vaccine hesitancy. Nature Medicine, 27, 1338–1339.
6. Puri, N., Coomes, E. A., Haghbayan, H., & Gunaratne, K. (2020). Social media and vaccine hesitancy: New updates for the era of COVID-19 and globalized infectious diseases. Human Vaccines & Immunotherapeutics, 16(11), 2586-2593.
7. Garett, R., & Young, S. D. (2021). Online misinformation and vaccine hesitancy. Translational Behavioral Medicine, ibab128. Advance online publication.
8. Paul, E., Steptoe, A., & Fancourt, D. (2021). Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health-Europe, 1, 100012.
9. Kreps, S. E., & Kriner, D. L. (2021). Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment. Vaccine.
10. Kricorian, K., & Turner, K. (2021). COVID-19 vaccine acceptance and beliefs among Black and Hispanic Americans. PloS one, 16(8), e0256122.
11. Ross, J., Diaz, C. M., & Starrels, J. L. (2020). The disproportionate burden of COVID-19 for immigrants in the Bronx, New York. JAMA Internal Medicine, 180(8), 1043-1044.
12. Dennis, C. L. (2003). Peer support within a health care context: A concept analysis. International Journal of Nursing Studies, 40(3), 321-332.
13. Hu, J., Wu, Y., Ji, F., Fang, X., & Chen, F. (2020). Peer support as an ideal solution for racial/ethnic disparities in colorectal cancer screening: Evidence from a systematic review and meta-analysis. Diseases of the Colon & Rectum, 63(6), 850-858.
14. Ramchand, R., Ahluwalia, S. C., Xenakis, L., Apaydin, E., Raaen, L., & Grimm, G. (2017). A systematic review of peer-supported interventions for health promotion and disease prevention. Preventive Medicine, 101, 156-170.
15. Matthias, M. S., McGuire, A. B., Kukla, M., Daggy, J., Myers, L. J., & Bair, M. J. (2015). A brief peer support intervention for veterans with chronic musculoskeletal pain: a pilot study of feasibility and effectiveness. Pain Medicine, 16(1), 81-87.
16. Executive Order (2012). Exec. Order No. 13625, 3 C.F.R. 302.
17. Cook, J. A. (2011). Peer-delivered wellness recovery services: From evidence to widespread implementation Editorial Psychiatric. Rehabilitation Journal, 35(2), 87-89.
18. Solomon, P. (2004). Peer support/peer provided services underlying processes, benefits, and critical ingredients. Psychiatric Rehabilitation Journal, 27(4), 392.
19. Akel, K. B., Masters, N. B., Shih, S. F., Lu, Y., & Wagner, A. L. (2021). Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China. Human Vaccines & Immunotherapeutics, 1-8.
20. Strully, K. W., Harrison, T. M., Pardo, T. A., & Carleo-Evangelist, J. (2021). Strategies to address COVID-19 vaccine hesitancy and mitigate health disparities in minority populations. Frontiers in Public Health, 9, 384.
21. Batra, K., Sharma, M., Dai, C. L., & Khubchandani, J. (2022). COVID-19 booster vaccination hesitancy in the United States: A multi-theory-model (MTM)-based national assessment. Vaccines, 10(5), 758.